Iradimed Co Stock In The News
| IRMD Stock | USD 53.93 0.35 0.65% |
Our overall analysis of Iradimed's news coverage and content from conventional and social sources shows investors' bearish mood towards Iradimed Co. The specific impact of Iradimed news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Iradimed's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Iradimed headlines in addition to utilizing other, more conventional financial analysis modules. Check out Iradimed Backtesting and Iradimed Hype Analysis.
Iradimed |
Iradimed Today Top News and Investor Outlook
Iradimed Co Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Iradimed and other traded companies coverage with news coverage. We help investors stay connected with Iradimed headlines for the 30th of November to make an informed investment decision based on correlating the impacts of news items on Iradimed Stock performance. Please note that trading solely based on the Iradimed Co hype is not for everyone as timely availability and quick action are needed to avoid losses.
Iradimed stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Iradimed earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Iradimed that are available to investors today. That information is available publicly through Iradimed media outlets and privately through word of mouth or via Iradimed internal channels. However, regardless of the origin, that massive amount of Iradimed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Iradimed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Iradimed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Iradimed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Iradimed alpha.
Iradimed Largest EPS Surprises
Earnings surprises can significantly impact Iradimed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-10-30 | 2020-09-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2019-04-30 | 2019-03-31 | 0.15 | 0.13 | -0.02 | 13 | ||
2015-04-30 | 2015-03-31 | 0.12 | 0.14 | 0.02 | 16 | ||
2021-04-30 | 2021-03-31 | 0.1 | 0.13 | 0.03 | 30 | ||
2020-04-30 | 2020-03-31 | 0.15 | 0.18 | 0.03 | 20 | ||
2019-02-06 | 2018-12-31 | 0.13 | 0.16 | 0.03 | 23 |
Iradimed Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Iradimed Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
26th of November 2024
Is There An Opportunity With IRADIMED CORPORATIONs 47 percent Undervaluation at finance.yahoo.com
7th of November 2024
iRadimed is on the Move, Heres Why the Trend Could be Sustainable at finance.yahoo.com
5th of November 2024
iRadimed Corp Stock Price Up 3.61 percent on Nov 5 at gurufocus.com
4th of November 2024
IRADIMED CORPORATION Named to Fortunes 100 Fastest Growing Companies List for 2024 at globenewswire.com
1st of November 2024
iRadimed Corp Q3 2024 Earnings Call Highlights Record Revenue Growth and Strategic Shifts at gurufocus.com
31st of October 2024
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration... at globenewswire.com
30th of October 2024
Iradimed Scheduled to Post Quarterly Earnings on Thursday at thelincolnianonline.com
23rd of October 2024
Iradimed Hits New 52-Week High Still a Buy at thelincolnianonline.com
17th of October 2024
Iradimed Corporation Sees Large Growth in Short Interest at thelincolnianonline.com
10th of September 2024
IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth Big 8 Investo... at globenewswire.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Iradimed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Iradimed's short interest history, or implied volatility extrapolated from Iradimed options trading.
Check out Iradimed Backtesting and Iradimed Hype Analysis. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iradimed. If investors know Iradimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iradimed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0) | Dividend Share 0.45 | Earnings Share 1.46 | Revenue Per Share 5.635 | Quarterly Revenue Growth 0.11 |
The market value of Iradimed is measured differently than its book value, which is the value of Iradimed that is recorded on the company's balance sheet. Investors also form their own opinion of Iradimed's value that differs from its market value or its book value, called intrinsic value, which is Iradimed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iradimed's market value can be influenced by many factors that don't directly affect Iradimed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iradimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Iradimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iradimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.